Oculis Holding AG Ordinary shares

OCSNASDAQ • USD
7.58 USD
↗ 0.09 (1.19%)🟢PRE MARKET (AS OF 07:31 PM EDT)
🟢Market: OPEN

OCS is currently priced at $7.58. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. This is driven by a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Oct 20, 2026.

Open?$7.29
High?$7.80
Low?$7.02
Prev. Close?$7.49
Volume?257.0K
Avg. Volume?N/A
VWAP?$7.55
Bid / Ask
Bid?$6.46 × 100
Ask?$9.72 × 100
Spread?$3.26
Midpoint?$8.09
Valuation & Ratios
Market Cap?450.8M
Shares Out?N/A
Float?44.2M
Float %?76.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
Employees
67
Market Cap
450.8M
Industry
N/A
Listed
2023-03-03
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?4.00%Low
Short Interest?1.8M
Days to Cover?6.5
Free Float44.2M
Avg Daily Volume273.3K
Settlement Date2026-09-30